This study highlights the potential of vimentin-FBXL14 complexes as a therapeutic strategy to target EMT-induced metastasis disease, and the targeting vimentin by IGFBP-3 contributing to our understanding of the better means to control cancer metastasis. Here, VIM is linked to cancer.